Digital Repository

Molecular Docking of Novel mPGES-1 Inhibitors

Show simple item record

dc.contributor.author Bezold, Elise
dc.contributor.author Gilliam, Kendyl
dc.date.accessioned 2021-09-20T13:09:09Z
dc.date.available 2021-09-20T13:09:09Z
dc.date.created 2021
dc.identifier.uri http://hdl.handle.net/11216/3970
dc.description 2021 Celebration of Student Research and Creativity presentation en_US
dc.description.abstract "Nonsteroidal anti- inflammatory drugs (NSAIDs) are the current treatment for inflammation; however, NSAIDs have led to severe cardiovascular and gastrointestinal side effects. Therefore, there is a significant need for next generation anti-inflammatory drugs that do not present these same side effects. This poster is focused on molecular docking studies of compounds as potential inhibitors of a microsomal prostaglandin E2 (mPGES- 1), a specific enzyme within the inflammatory pathway known to prevent these severe side effects. The top docking scores will then be compared to biological data, which will lead to a structure-activity relationship that will be applied to further analogue design." en_US
dc.description.uri https://youtu.be/PmzzO_tALS0 en_US
dc.language.iso en_US en_US
dc.publisher Northern Kentucky University en_US
dc.relation.ispartofseries Celebration of Student Research and Creativity;2021
dc.subject Nonsteroidal anti-inflammatory agents en_US
dc.subject Molecular docking simulations en_US
dc.subject Drugs Side effects en_US
dc.title Molecular Docking of Novel mPGES-1 Inhibitors en_US
dc.type Presentation en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record